Table 4.

Most common treatment-emergent adverse events (TEAEs)^a

TEAE	Vixotrigine alone (n = 36)	Oral contraceptive alone (n = 36)	Vixotrigine + oral contraceptive (n = 36)	Overall (N = 36)
Any adverse event	6 (16.7)	5 (13.9)	6 (16.7)	17 (47.2)
Alanine aminotransferase increased	0	1 (2.8)	2 (5.6)	3 (8.3)
Headache	1 (2.8)	1 (2.8)	1 (2.8)	3 (8.3)
Upper respiratory tract infection	2 (5.6)	0	1 (2.8)	3 (8.3)
Cough	1 (2.8)	0	1 (2.8)	2 (5.6)

Data are participants [n (%)]

^aEvents occurring in > 1 participant